Neuroscience | Penn Today

Drilling into a model of a skull: a ‘cool’ taste of doctoring for Philly high schoolers

The “Pipeline Plus” summer program at Penn Medicine, run by the Netter Center for Community Partnerships, is designed to teach Philadelphia high school students about careers in the health sciences.

A new study finds a strong link between depression and dementia

A study led by Holly C. Elser of the Perelman School of Medicine finds that adults diagnosed with depression are more than twice as likely to get dementia later in life.

Young and middle-aged adults with depression face greater dementia risk later in life

A study led by Holly C. Elser of the Perelman School of Medicine suggests a connection between dementia risk and depression diagnoses in early and mid-life.

Is Parkinson’s disease an industrial disorder of our making?

In an op-ed, Anjan Chatterjee of the Perelman School of Medicine examines Parkinson’s disease and its connection to industrialization.

AI-guided brain stimulation aids memory in traumatic brain injury

A collaborative study shows that targeted electrical stimulation in the brains of epilepsy patients with traumatic brain injury improved memory recall by 19%.

Prescribed stimulants for ADHD and the risk of addiction

Russell Ramsay of the Perelman School of Medicine writes about stimulants as a treatment for ADHD.

Study links social isolation with shrinking brain

Danielle Sandsmark of the Perelman School of Medicine says that many factors influence dementia risk, and social isolation would be just one.

Increasing health equity in Alzheimer’s disease research

The University of Pennsylvania is included in a national outreach and recruitment effort for a $46 million grant from the National Institutes of Health to assist in the inclusion and health equity of treating Alzheimer’s disease in Black patients.

New federal decisions make Alzheimer’s drug Leqembi widely accessible

Jason Karlawish of the Perelman School of Medicine is quoted on the risks and benefits of a new Alzheimer’s medication.

Challenges and advances in brain-computer interfaces

Following FDA approval for tech startups to begin human clinical trials for brain-computer interfacing technologies, Penn Today met with Anna Wexler of the Perelman School of Medicine to discuss the promising possibilities and potential pitfalls of neurotechnology.

Filters